Senseonics Holdings (SENS) Change in Accured Expenses (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Change in Accured Expenses came in at -$62000.0 in Q1 2026, up 98.9% year-on-year from -$31170.9 in Q1 2025, and up 89.24% on a QoQ basis from -$576000.0 in Q4 2025.
Senseonics Holdings (SENS) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Change in Accured Expenses data on file, last reported at -$62000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 98.9% year-over-year to -$62000.0 in Q1 2026; TTM through Mar 2026 was $5.1 million, a 222.88% increase from a year earlier, with the FY2025 full-year figure at -$490000.0, down 669.77% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$62000.0, up from -$576000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for SENS reached as high as $3.1 million in Q2 2025 and fell as low as -$5.7 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged -$95411.8 across 5 years, with a median of -$62000.0 in 2022.
- Across the five-year window, Change in Accured Expenses soared 1660.0% in 2023 and tumbled 430.34% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $975000.0 in 2022, then plunged by 178.87% to -$769000.0 in 2023, then soared by 136.15% to $278000.0 in 2024, then slumped by 307.19% to -$576000.0 in 2025, then jumped by 89.24% to -$62000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$62000.0 in Q1 2026, -$576000.0 in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Senseonics Holdings | 229.57 Mn | 165.25 Mn | 6.94 Mn | -62,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,000.00 |
| Mar 31, 2026 | -62,000.00 |
| Dec 31, 2025 | -576,000.00 |
| Dec 31, 2025 | -576,000.00 |
| Sep 30, 2025 | 2.62 Mn |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 3.12 Mn |
| Mar 31, 2025 | -5.66 Mn |
| Mar 31, 2025 | -5.66 Mn |
| Dec 31, 2024 | 278,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | -540,000.00 |
| Sep 30, 2024 | -540,000.00 |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | -1.42 Mn |
| Mar 31, 2024 | -1.42 Mn |
| Dec 31, 2023 | -769,000.00 |
| Dec 31, 2023 | -769,000.00 |